Autografting in Philadelphia (Ph)+ chronic myeloid leukaemia using cultured marrow: an update of a pilot study.

2.50
Hdl Handle:
http://hdl.handle.net/10541/94878
Title:
Autografting in Philadelphia (Ph)+ chronic myeloid leukaemia using cultured marrow: an update of a pilot study.
Authors:
Coutinho, Lucia H; Chang, James; Brereton, M L; Morgenstern, Godfrey R; Scarffe, J Howard; Harrison, Christine J; Yin, J A; Darbyshire, P J; Burdach, S; Dexter, T Michael; Testa, Nydia G
Abstract:
Incubation of CML marrow in long-term culture (LTC) conditions may result in selection of normal (Ph-) LTC-initiating cells (LTC-IC) as early as 10 days, and in production of Ph- clonogenic cells and mature end cells within 5 weeks. This was the rationale for using marrow cells from 10-day-old LTC to autograft nine chronic phase CML patients, ineligible for HLA-matched sibling donor transplant, and who were selected on the basis of a pre-transplant screening LTC test. Of the transplanted patients three died; two of graft failure and one of therapy-related toxicity with 97% Ph- cells 16 months following the autograft. The reconstituting haemopoietic cells in the seven engrafted patients were 100% Ph- in four, > or = 90% Ph- in two and 71% Ph- in the seventh, with a duration of complete cytogenetic response of 6-12 months. Three patients reverted to chronic phase and 100% Ph+ haemopoiesis 27-36 months post-autograft. The other three patients remain in continuous haematological remission with 22% Ph- cells in one and complete cytogenetic remission in the other two 3-4 years post-autograft. IFN therapy was generally introduced on the first evidence of recurrence of Ph+ cells or of cytogenetic deterioration. Further strategies to modulate immune surveillance in vivo may improve the outcome of cultured marrow autografts which give an initial and rather prolonged bias towards Ph- haemopoiesis.
Affiliation:
CRC Department of Experimental Haematology, Paterson Institute for Cancer Research, Christie Hospital, Manchester, UK.
Citation:
Autografting in Philadelphia (Ph)+ chronic myeloid leukaemia using cultured marrow: an update of a pilot study. 1997, 19 (10):969-76 Bone Marrow Transplant.
Journal:
Bone Marrow Transplantation
Issue Date:
May-1997
URI:
http://hdl.handle.net/10541/94878
DOI:
10.1038/sj.bmt.1700777
PubMed ID:
9169640
Type:
Article
Language:
en
ISSN:
0268-3369
Appears in Collections:
All Christie Publications ; All Paterson Institute for Cancer Research

Full metadata record

DC FieldValue Language
dc.contributor.authorCoutinho, Lucia Hen
dc.contributor.authorChang, Jamesen
dc.contributor.authorBrereton, M Len
dc.contributor.authorMorgenstern, Godfrey Ren
dc.contributor.authorScarffe, J Howarden
dc.contributor.authorHarrison, Christine Jen
dc.contributor.authorYin, J Aen
dc.contributor.authorDarbyshire, P Jen
dc.contributor.authorBurdach, Sen
dc.contributor.authorDexter, T Michaelen
dc.contributor.authorTesta, Nydia Gen
dc.date.accessioned2010-03-24T14:20:44Z-
dc.date.available2010-03-24T14:20:44Z-
dc.date.issued1997-05-
dc.identifier.citationAutografting in Philadelphia (Ph)+ chronic myeloid leukaemia using cultured marrow: an update of a pilot study. 1997, 19 (10):969-76 Bone Marrow Transplant.en
dc.identifier.issn0268-3369-
dc.identifier.pmid9169640-
dc.identifier.doi10.1038/sj.bmt.1700777-
dc.identifier.urihttp://hdl.handle.net/10541/94878-
dc.description.abstractIncubation of CML marrow in long-term culture (LTC) conditions may result in selection of normal (Ph-) LTC-initiating cells (LTC-IC) as early as 10 days, and in production of Ph- clonogenic cells and mature end cells within 5 weeks. This was the rationale for using marrow cells from 10-day-old LTC to autograft nine chronic phase CML patients, ineligible for HLA-matched sibling donor transplant, and who were selected on the basis of a pre-transplant screening LTC test. Of the transplanted patients three died; two of graft failure and one of therapy-related toxicity with 97% Ph- cells 16 months following the autograft. The reconstituting haemopoietic cells in the seven engrafted patients were 100% Ph- in four, > or = 90% Ph- in two and 71% Ph- in the seventh, with a duration of complete cytogenetic response of 6-12 months. Three patients reverted to chronic phase and 100% Ph+ haemopoiesis 27-36 months post-autograft. The other three patients remain in continuous haematological remission with 22% Ph- cells in one and complete cytogenetic remission in the other two 3-4 years post-autograft. IFN therapy was generally introduced on the first evidence of recurrence of Ph+ cells or of cytogenetic deterioration. Further strategies to modulate immune surveillance in vivo may improve the outcome of cultured marrow autografts which give an initial and rather prolonged bias towards Ph- haemopoiesis.en
dc.language.isoenen
dc.subjectHaematopoiesisen
dc.subjectLeukaemiaen
dc.subject.meshAdult-
dc.subject.meshBone Marrow-
dc.subject.meshBone Marrow Purging-
dc.subject.meshBone Marrow Transplantation-
dc.subject.meshCells, Cultured-
dc.subject.meshChild-
dc.subject.meshCytogenetics-
dc.subject.meshFemale-
dc.subject.meshGraft Survival-
dc.subject.meshHematopoiesis-
dc.subject.meshHumans-
dc.subject.meshLeukemia, Myelogenous, Chronic, BCR-ABL Positive-
dc.subject.meshMale-
dc.subject.meshMiddle Aged-
dc.subject.meshPhiladelphia Chromosome-
dc.subject.meshPilot Projects-
dc.subject.meshTime Factors-
dc.subject.meshTransplantation, Autologous-
dc.titleAutografting in Philadelphia (Ph)+ chronic myeloid leukaemia using cultured marrow: an update of a pilot study.en
dc.typeArticleen
dc.contributor.departmentCRC Department of Experimental Haematology, Paterson Institute for Cancer Research, Christie Hospital, Manchester, UK.en
dc.identifier.journalBone Marrow Transplantationen

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.